RxDoctor Payments Data

Sandy Christiansen, MD

Pain Medicine · Portland, ORNPI 1407112832

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,292 of the $3,017 with a category attached, or 76.0%. 9 manufacturers reported payments, led by Pacira Pharmaceuticals Incorporated at 24.0% of the total. Reporting peaked in 2023 at $1,262 and has fallen 84.4% since, to $196 in 2025.

$3,017in general payments, 2019–2025

Across 23 payments — averaging $131.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pacira Pharmaceuticals Incorporated$725
  • Medtronic$655
  • Abbott$564
  • MML US, Inc.$255
  • Biotronik NRO, Inc.$212
  • SPR Therapeutics, Inc$203
  • plus $403 from 3 others
$99,667in research payments, 2019–2025

Across 20 payments — averaging $4983.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Avanos Medical$100K

What the payments were for

  • Speaking & faculty fees$72524%
  • Food & beverage$2,29276%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,017 in reported general payments places this provider in the 55th percentile of 57 pain medicine providers in Oregon.

See all pain medicine providers in Oregon

Medicare billing

Part B allowed, 2024
$25,508
Medicare patients
94
Services billed
311

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pain medicine in Portland

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →